Key statistics
As of last trade Philogen SpA (PHIL:MIL) traded at 19.95, -8.90% below its 52-week high of 21.90, set on Aug 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.95 |
---|---|
High | 20.00 |
Low | 19.85 |
Bid | 19.85 |
Offer | 19.95 |
Previous close | 19.95 |
Average volume | 6.87k |
---|---|
Shares outstanding | 29.24m |
Free float | 10.97m |
P/E (TTM) | -- |
Market cap | 583.40m EUR |
EPS (TTM) | -0.7301 EUR |
Data delayed at least 15 minutes, as of Nov 22 2024 12:45 GMT.
More ▼
- Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
- Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors